No CrossRef data available.
Article contents
A Case of Stroke and Blindness
Published online by Cambridge University Press: 23 September 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Clinical Neuropathological Conference
- Information
- Copyright
- Copyright © The Canadian Journal of Neurological 2013
References
1.CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE steering committee. Lancet. 1996;348(9038):1329–39.Google Scholar
2.Marini, C, De Santis, F, Sacco, S, et al.Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke. 2005;36(6):1115–19.Google Scholar
3.Zwicker, J, Atkins, EJ, Lum, C, et al.An atypical presentation of giant cell arteritis. CMAJ. 2011;183(5):E301–5.CrossRefGoogle ScholarPubMed
4.Tang, V, Fantaneanu, T, Chakraborty, S, et al.Letter to the editor. Intracranial non-occlusive thrombus and multiple strokes in giant cell arteritis. Can J Neurol Sci. 2012;39(1):116–17.Google Scholar
5.Siatkowski, RM, Gass, JD, Glaser, JS, et al.Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol. 1993;115(1):57–63.Google Scholar
6.Hunder, GG.Epidemiology of giant-cell arteritis. Cleve Clin J Med. 2002;69 Suppl 2:SII79–82.Google Scholar
7.Carroll, SC, Gaskin, BJ, Danesh-Meyer, HV.Giant cell arteritis. Clin Experiment Ophthalmol. 2006;34(2):159–73.CrossRefGoogle ScholarPubMed
8.Caselli, RJ, Hunder, GG.Neurologic complications of giant cell (temporal) arteritis. Semin Neurol. 1994;14(4):349–53.CrossRefGoogle ScholarPubMed
9.Chew, SS, Kerr, NM, Danesh-Meyer, HV.Giant cell arteritis. J Clin Neurosci. 2009;16(10):1263–8.CrossRefGoogle ScholarPubMed
10.Caselli, RJ, Hunder, GG, Whisnant, JP.Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology. 1988;38(3):352–9.CrossRefGoogle ScholarPubMed
11.Reich, KA, Giansiracusa, DF, Strongwater, SL.Neurologic manifestations of giant cell arteritis. Am J Med. 1990;89(1):67–72.Google Scholar
12.Brack, A, Martinez-Taboada, V, Stanson, A, et al.Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42(2):311–17.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
13.Evans, J, Hunder, GG.The implications of recognizing large-vessel involvement in elderly patients with giant cell arteritis. Curr Opin Rheumatol. 1997;9(1):37–40.Google Scholar
14.Hunder, GG, Bloch, DA, Michel, BA, et al.The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–8.Google Scholar
15.Quinn, EM, Kearney, DE, Kelly, J, et al.Temporal artery biopsy is not required in all cases of suspected giant cell arteritis. Ann Vasc Surg. 2012;26(5):649–54.Google Scholar
16.Garcia-Garcia, J, Ayo-Martin, O, Argandona-Palacios, L, et al.Vertebral artery halo sign in patients with stroke: a key clue for the prompt diagnosis of giant cell arteritis. Stroke. 2011;42(11):3287–90.Google Scholar
17.Wiszniewska, M, Devuyst, G, Bogousslavsky, J.Giant cell arteritis as a cause of first-ever stroke. Cerebrovasc Dis. 2007;24(2-3):226–30.Google Scholar
You have
Access